EichorEICHOR
Condition: Lung Resection Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Lung Resection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Patient Reported Outcomes Targeting Early Chest Tube Removal (PROTECTR) Study
NA · 1 location(s) · London Health Sciences Centre Research Institute OR Lawson R · NCT06444854Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive)
Phase 2 · 2 location(s) · Samsung Medical Center · NCT04591002Radical Resection With Contralateral Lymph Node Dissection for Clinical N3 NSCLC
NA · 2 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT07003490Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung Cancer
Phase 2 · 1 location(s) · Zhujiang Hospital · NCT07534033A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · 69 location(s) · Shanghai Henlius Biotech · NCT07160335Risk Factors for AKI in Patients Undergoing VATS for Pulmonary Resection
Phase N/A · 1 location(s) · Atatürk Chest Diseases and Chest Surgery Training and Resear · NCT06341933Real-World Outcomes of Resected EGFR-Mutated NSCLC Patients Treated With Adjuvant EGFR-TKI in China
Phase N/A · 1 location(s) · AstraZeneca · NCT07593248Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.
Phase 2 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT06492421Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With P
Phase 2 · 13 location(s) · Greg Durm, MD · NCT04317534Impact of Sugammadex Versus Neostigmine on Early Postoperative Pulmonary Function
NA · 3 location(s) · Shanghai Pulmonary Hospital, Shanghai, China · NCT07309393Evaluating the Association of Force Feedback With Outcomes After Lung Resection Using the da Vinci Multiport System
Phase N/A · 1 location(s) · Ohio State University · NCT07660900Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin
Phase 2 · 1 location(s) · Ayal A. Aizer, MD · NCT07132190Primary Tumor Resection for M1a Stage Lung Cancer
Phase N/A · 1 location(s) · Fudan University · NCT06547710Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · 370 location(s) · Eli Lilly and Company · NCT06890598Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
Phase N/A · 1 location(s) · University of Colorado, Denver · NCT05517811A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · 229 location(s) · Merck Sharp & Dohme LLC · NCT06077760Pulmonary Watershed Topographic Map Navigation for Lung Nodule Resection
NA · 1 location(s) · Guangdong Provincial People's Hospital · NCT06404164Perioperative Statins to Prevent AFib After Lung Surgery
Phase 4 · 2 location(s) · Peking Union Medical College Hospital · NCT07727681Bronchoscopic Navigation Robot-guided Dye Marking-assisted Thoracoscopic Pulmonary Nodule Resection
NA · 1 location(s) · Ruijin Hospital · NCT06821451Registry of the Spanish Society of Thoracic Surgery
Phase N/A · 1 location(s) · Sociedad Española de Cirugía Torácica · NCT05600569Prospective Trial of Induction Immunotherapy in Locally Advanced or Oligometastatic NSCLC Without a Primary Curative Opt
Phase N/A · 1 location(s) · Klinikum Esslingen · NCT04926584Early Postoperative Day 0 Chest Tube Removal After Thoracoscopic Minor Surgeries
NA · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT04670523Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously
Phase 3 · 32 location(s) · Fundación GECP · NCT06431633Osimertinib Therapy After Resection in High-risk Stage I EGFRm NSCLC (OSTAR)
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT05686434Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients
Phase 1 · 1 location(s) · Massachusetts General Hospital · NCT03535545A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed No
Phase 3 · 35 location(s) · ETOP IBCSG Partners Foundation · NCT06931717Cognitive and Physical Optimization in Prevention of Postoperative Cognitive Deficit in Elderly With Lung Resection
NA · 1 location(s) · Military Medical Academy, Belgrade, Serbia · NCT06339268A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (M
Phase 3 · 46 location(s) · Merck Sharp & Dohme LLC · NCT07513376Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Phase 1 · 3 location(s) · Exscientia AI Ltd., a wholly owned subsidiary of Recursion P · NCT07517198SNB-101 for Treatment of Extensive Stage Small Cell Lung Cancer
Phase 1/Phase 2 · 1 location(s) · SN BioScience · NCT07391813
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.